Retraction
PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors
Paper Information
Record ID:
44531
Author(s):
Journal:
Publication Date:
November 02, 2022
Retraction Date:
May 13, 2023
(2.5 years years ago)
Subjects:
Institutions:
- Cancer and Cell Biology Division, The Translational Genomics Research Institute, Phoenix, AZ 85004, USA
- Collaborative Center for Translational Mass Spectrometry, The Translational Genomics Research Institute, Phoenix, AZ 85004, USA
- Ludwig Cancer Research, San Diego Branch, La Jolla, CA 92093, USA
- Department of Pathology, University of California San Diego, 9500 Gilman Dr., La Jolla, CA 92093, USA
Country:
🇺🇸 United StatesArticle Type:
Publisher:
Oxford Academic
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (9)
9
Total Citations6
Post-Retraction(66.7%)
2
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
5
Within 1 year
0
After 2+ years
557
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Comprehensive multi-omics analysis elucidates colchicine-induced toxicity mechanisms and unveils the therapeutic potential of MLN4924 and kinase inhibitors
Linhui Zhai, Xinglong Jia, Yu-Lu Chen et al. (17 authors)
Acta Pharmacologica Sinica
Published: Nov 2024
2 citations
2 citations
557 days after retraction
Extent of Resection Thresholds in Molecular Subgroups of Newly Diagnosed Isocitrate Dehydrogenase–Wildtype Glioblastoma
Antonio Dono, Ping Zhu, Takeshi Takayasu et al. (8 authors)
Neurosurgery
Published: Apr 2024
8 citations
8 citations
353 days after retraction
EZH2-H3K27me3-mediated silencing of mir-139-5p inhibits cellular senescence in hepatocellular carcinoma by activating TOP2A
Ke Wang, Xunliang Jiang, Yu Jiang et al. (10 authors)
Journal of Experimental & Clinical Cancer Research
Open Access
Published: Nov 2023
26 citations
26 citations
198 days after retraction
Emerging trends in post-translational modification: Shedding light on Glioblastoma multiforme
Smita Kumari, Rohan Gupta, Rashmi K. Ambasta et al. (4 authors)
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Published: Oct 2023
8 citations
8 citations
158 days after retraction
Discovery of neddylation E2s inhibitors with therapeutic activity
MAA Mamun, Ying Liu, Yin-Ping Geng et al. (9 authors)
Oncogenesis
Open Access
Published: Sep 2023
5 citations
5 citations
126 days after retraction
The regulation of PTEN: Novel insights into functions as cancer biomarkers and therapeutic targets
Jie Liu, Yongli Pan, Yuheng Liu et al. (7 authors)
Journal of Cellular Physiology
Published: Jun 2023
15 citations
15 citations
36 days after retraction
Progress in targeting PTEN/PI3K/Akt axis in glioblastoma therapy: Revisiting molecular interactions
Mehrdad Hashemi, Sara Etemad, Sahar Rezaei et al. (17 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Jan 2023
86 citations
86 citations
129 days before retraction
Activation of the β‑TrCP/IκBα/inflammation axis limits the sensitivity of liver cancer cells to neddylation inhibition
Haojun Xiong, Dandan Zheng, Ying Liu et al. (7 authors)
Oncology Reports
Open Access
Published: Sep 2022
2 citations
2 citations
228 days before retraction
Quick Stats
Total Citations:
10
Years Since Retraction:
2.5 years
Open Access:
Yes
Last Checked:
Jul 24, 2025